A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

BACKGROUND: No drug treatment to date has shown convincing clinical evidence of restoring cognitive function or preventing further decline after stroke. The ongoing ARTEMIDA study will evaluate the efficacy and safety of Actovegin for the symptomatic treatment of post-stroke cognitive impairment (PS...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Guekht, Alla, Skoog, Ingmar, Korczyn, Amos D., Zakharov, Vladimir, Eeg, Martin, Vigonius, Ulf
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: S. Karger AG 2013
विषय:
Original Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3919431/
https://ncbi.nlm.nih.gov/pubmed/24516413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000357122
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन